SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001564590-18-005959
Filing Date
2018-03-16
Accepted
2018-03-16 09:31:05
Documents
7
Period of Report
2018-04-26
Effectiveness Date
2018-03-16

Document Format Files

Seq Description Document Type Size
1 DEF 14A - 2017 evok-def14a_20180426.htm DEF 14A 1317514
2 GRAPHIC g201803131943179075845.jpg GRAPHIC 4419
3 GRAPHIC g201803131943244195848.jpg GRAPHIC 2754
4 GRAPHIC g201803131943248395849.jpg GRAPHIC 44668
5 GRAPHIC g201803131943179615847.jpg GRAPHIC 4489
6 GRAPHIC g201803131943248635850.jpg GRAPHIC 36735
7 GRAPHIC g201803131943179425846.jpg GRAPHIC 2530
  Complete submission text file 0001564590-18-005959.txt   1451195
Mailing Address 420 STEVENS AVENUE SUITE 370 SOLANA BEACH CA 92075
Business Address 420 STEVENS AVENUE SUITE 370 SOLANA BEACH CA 92075 858-345-1494
Evoke Pharma Inc (Filer) CIK: 0001403708 (see all company filings)

IRS No.: 208447886 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-36075 | Film No.: 18694378
SIC: 2834 Pharmaceutical Preparations